Life Science Investor Malin To Return €150M To Shareholders
Malin Corporation said Wednesday it plans to return up to €150 million ($156 million) of capital to shareholders by repurchasing stock, a program expected to lower the life science investor's outstanding...To view the full article, register now.
Already a subscriber? Click here to view full article